Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05758181
Other study ID # 1999193
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date August 9, 2023
Est. completion date August 1, 2024

Study information

Verified date September 2023
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

When patients have surgery on the neck, trunk, arms, or legs, stitches are the standard way to close the wound. Wounds always result in a scar, but doctors are always looking for ways to reduce scarring. Several studies have been done to test ways to close wounds that reduce scarring. One idea is to reduce the tension around the cut. One way to reduce tension is to free up the skin around the wound. This procedure is also called "undermining". Some studies have shown that freeing up the skin near the tips of the wound, called the "apices," is helpful for improving the cosmetic outcome of scars. This study will investigate if there are any differences in the appearances of the scar if one tip is undermined and the other is not.


Description:

Reducing scar tissue formation and postoperative complications in wound closure has remained the focus of recent studies and decreases the cost and time burden of follow-up visits and procedures. Such studies have highlighted the impact of mechanical forces and tension on scar formation, demonstrating that reducing the mechanical stress within the wound environment results in better aesthetic outcomes. Undermining peripheral and apices of the wound has been used in the closure of large and tight defects allowing the closure of these wounds by reducing the tension. Undermining has been shown to reduce tension, and peripheral and apical undermining has been recommended for decreasing scar formation. However, extensive undermining may increase the complications of the surgery by reducing vascularization and creating a space for hematomas. To our knowledge, the impact of scar cosmesis and the rate of postoperative complications in apical undermining in the linear repair of surgical wounds have not been studied, and it remains unknown whether undermining the apices can decrease the protrusion of the scar tissue at the edges. This study seeks to determine the effectiveness of apical undermining of linear wound closures in improving scar cosmesis by using individuals as their own controls in a split-scar model. This is a single center, randomized, evaluator-blinded, split wound study. After screening and informed consent, demographic data will be collected including age, race, gender, and medical record number. This will be collected within the Redcap database. The patient's wound will be labeled A if it is on the left or superior side of the investigator and B if it is on the right or inferior side. A concealed randomization result will be obtained from the Redcap randomization module, which will specify which side, A or B, will receive apical undermining Following this, both sides of the wound will be sutured together with a subcutaneous (bottom) layer of stitches. Next, a cutaneous layer of sutures will be placed, as is the standard of care. A digital image of the wound after the epidermal closure will be obtained; these may be used in scientific talks and/or for publication purposes. The patient will then be instructed to continue dressing changes along the entire length of the surgical site until the wound is fully healed as is the standard of care. Treatment assignment, wound length, demographic data, and digital images will be recorded within the Redcap database. Follow-up assessment will be scheduled for three months following the procedure, with a one-month window before or after that time if the patient cannot return at precisely three months.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 50
Est. completion date August 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - Able to give informed consent themselves - Patient scheduled for cutaneous surgical procedure on the neck, trunk, and extremities with predicted primary closure - Willing to return for follow-up visit Exclusion Criteria: - Incarceration - Under 18 years of age - Pregnant women - Unable to understand written and oral English - Wounds with predicted closure length less than 3cm

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Apical Undermining
The skin at the tip of the wound will be freed to reduce tension.

Locations

Country Name City State
United States University of California, Davis - Dermatology Department Sacramento California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Country where clinical trial is conducted

United States, 

References & Publications (5)

Barnes LA, Marshall CD, Leavitt T, Hu MS, Moore AL, Gonzalez JG, Longaker MT, Gurtner GC. Mechanical Forces in Cutaneous Wound Healing: Emerging Therapies to Minimize Scar Formation. Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):47-56. doi: 10.1089/wound.2016.0709. — View Citation

Gurtner GC, Dauskardt RH, Wong VW, Bhatt KA, Wu K, Vial IN, Padois K, Korman JM, Longaker MT. Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann Surg. 2011 Aug;254(2):217-25. doi: 10.1097/SLA.0b013e318220b159. — View Citation

Jonathan K (Ed). Dermatologic Surgery. McGraw-Hill Education. 2018. ISBN: 978-1-25-964392-7.

Krishnan NM, Brown BJ, Davison SP, Mauskar N, Mino M, Jordan MH, Shupp JW. Reducing Wound Tension with Undermining or Imbrication-Do They Work? Plast Reconstr Surg Glob Open. 2016 Jul 13;4(7):e799. doi: 10.1097/GOX.0000000000000799. eCollection 2016 Jul. — View Citation

Zitelli JA. TIPS for a better ellipse. J Am Acad Dermatol. 1990 Jan;22(1):101-3. doi: 10.1016/0190-9622(90)70016-b. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Observer Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS) The primary endpoint will be the score of two blinded reviewers independently using the POSAS assessment. The observer scale of the POSAS consists of six items (vascularity, pigmentation, thickness, relief, pliability, and surface area). All items are scored on a scale ranging from 1 ("like normal skin") to 10 ("worst scar imaginable"). The sum of the six items results in a total score of the POSAS observer scale. Furthermore, an overall opinion is scored on a scale ranging from 1 to 10. All parameters should preferably be compared to normal skin on a comparable anatomic location. 3 months
Secondary Patient Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS) This is the patient portion of the POSAS assessment, which will be independently recorded. The patient scale of the POSAS consists of six items (pain, itch, thickness, color, stiffness, and irregularity). All items are scored on a scale ranging from 1 ("as normal skin") to 10 ("yes, very different"). The sum of the six items results in a total score of the POSAS patient scale. Furthermore, an overall opinion is scored on a scale ranging from 1 to 10. 3 months
Secondary Width of Scar as measured using Trace-to-Tape Method The trace-to-tape method is an objective measure for linear postoperative scars. The mean scar width will be determined using the trace-to-tape method. The surface area of the scar will be collected by tracing the scar with a water-based gel pen. While still wet, the gel residue will be lifted from the skin with clear packing tape and transferred on a sheet of paper. 3 months
Secondary Complications or Adverse Events from Treatment For example, if one half of the scar has more associated erythema, as measured using the Trace-to-Tape method, then it will be recorded. Other complications from the treatment will also be recorded. 3 months
See also
  Status Clinical Trial Phase
Withdrawn NCT01995604 - Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face N/A
Completed NCT05449457 - Aesthetic Outcome of Layered Closure vs. Layered Closure Followed by 2-Octyl Cyanoacrylate N/A
Withdrawn NCT01704924 - Prospective Observation of Wound Healing With Prevena Incision Management System N/A
Recruiting NCT05758168 - Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds N/A
Completed NCT03424304 - Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment N/A
Completed NCT02300909 - dHACM in Lumbar Decompression and Microdiscectomy Surgery N/A
Active, not recruiting NCT04383912 - Onabotulinum Toxin A in Direct Brow Lift N/A
Not yet recruiting NCT04593706 - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) N/A
Enrolling by invitation NCT06448481 - Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure N/A
Not yet recruiting NCT05470322 - Efficacy and Tolerability of a Fractional Ablative Erbium Laser for Axillary Scarring for Hidradenitis Suppurativa Patients N/A
Recruiting NCT06122090 - Treatment of Hypopigmented Scars With Bimatoprost Phase 2
Completed NCT04331080 - A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery Phase 2/Phase 3
Completed NCT03036306 - Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions Phase 1
Completed NCT02630303 - High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin Phase 1
Completed NCT02088567 - Amniotic Membrane in Total Knee Replacements to Reduce Scarring N/A
Completed NCT03514615 - A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers. Phase 1
Completed NCT02676115 - Medipore Tape Study N/A
Completed NCT03424148 - Open-label, Prospective, Multicenter Study to Evaluate the Cutera Excel V™ Laser and a Micro-Lens Array Attachment N/A
Not yet recruiting NCT04214236 - CiNPT for Abdominoplasties in Post-bariatric Patients Study N/A
Completed NCT02247193 - Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair Phase 1/Phase 2